4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0001193125-25-307251
See Remarks sold 20,000 shares at $79.52 ($1,590,490)
- See Remarks acquired 20,000 shares (option exercise)
- See Remarks acquired 410 shares (grant or award)
- See Remarks gave up 135 shares (to pay taxes)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Maduck Sean See Remarks | 2025-12-01 | Option exercise 10b5-1 | +20,000 | $8.27 | $165,400 | 27,904 | D: show line 1 in the form |
| Maduck Sean See Remarks | 2025-12-01 | Sale 10b5-1 | −20,000 | $79.52 | $1,590,490 | 7,904 | D: show line 2 in the form |
| Maduck Sean See Remarks | 2025-12-01 | Grant or award 10b5-1 | +205 | $79.78 | $16,355 | 8,109 | D: show line 3 in the form |
| Maduck Sean See Remarks | 2025-12-01 | Grant or award 10b5-1 | +205 | 8,314 | D: show line 4 in the form | ||
| Maduck Sean See Remarks | 2025-12-02 | Shares withheld for taxes 10b5-1 | −135 | $79.78 | $10,770 | 8,179 | D: show line 5 in the form |
| Open-market sales · 20,000 sh · avg $79.52 · $1,590,490 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Maduck Sean See Remarks | 2025-12-01 | Option exercise · Stock option (right to buy) 10b5-1 | −20,000 | 241,986 | D: show line 6 in the form |
Loading xslF345X05/ownership.xml…